 |
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.
Learn more about Zorbtive.
No reviews have yet been submitted. Be the first to review this drug.
Jan 31, 2012 - NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine...
Dec 1, 2011 - NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine...
Four abstracts, including new data from STEPS 2, presented at American College of Gastroenterology Annual Scientific Meeting BEDMINSTER, N.J.--Oct. 31,...
Studies support the efficacy of GATTEX (teduglutide) in patients with short bowel syndrome Abstracts can be viewed online BEDMINSTER, N.J.--(BUSINESS...
Aug 18, 2011 - NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine...
Looking for answers? Ask a question or go join the Zorbtive support group to connect with others who have similar interests.
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Data sources include Micromedex™ (updated Jan 27th, 2011), Cerner Multum™ (updated Jan 3rd, 2012), Wolters Kluwer™ (updated Jan 31st, 2012) and others.
To view content sources and attributions, refer to our editorial policy.
Copyright © 2000-2012 Drugs.com. All rights reserved.
We comply with the HONcode standard for trustworthy health information.
Verify here
